Status:
COMPLETED
Early- and Late-onset Candidemia
Lead Sponsor:
Giovanni Di Perri
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Candidemia
Eligibility:
All Genders
18+ years
Brief Summary
A timing diagnosis of candidemia is as important as the correct choice of empiric or targeted antifungal therapy. In the last years a growing body of knowledge has better characterized health-care ass...
Eligibility Criteria
Inclusion
- Candidemia diagnosed with positive blood culture either from a peripheral vein or CVC
Exclusion
- Candida isolated from a removed CVC tip will not be considered
Key Trial Info
Start Date :
May 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT01406093
Start Date
May 1 2011
End Date
June 1 2012
Last Update
December 4 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital San Giovanni Battista - Molinette
Torino, Italy, 10100